A

Ankara University | Ibni-Sina Hospital - Rheumatology Department

Research site

(Unclaimed)

Location

Talatpasa Bulvari, Ibni-Sina Hospital, Ankara, Ankara, Turkey

Site insights

Top conditions

Top treatments

PCI-32765

CRB-701

Teclistamab

Ibrutinib

Lenalidomide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Long-term Extension Study of PCI-32765 (Ibrutinib) (CAN3001)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to i...

Invitation-only

Waldenstrom Macroglobulinemia

Follicular Lymphoma

Drug: Ibrutinib

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

The goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein ca...

Enrolling

Solid Tumor, Adult

Drug: CRB-701

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)

This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclis...

Enrolling

Multiple Myeloma

Drug: Teclistamab

Drug: Lenalidomide